Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TNFRSF1A | P19438 | 1/20 | 0.84 |
| ▸ | MAPT | P10636 | 7/20 | 0.76 |
| ▸ | LMNA | P02545 | 3/20 | 0.76 |
| ▸ | CTSL | P07711 | 2/20 | 0.76 |
| ▸ | CTSB | P07858 | 2/20 | 0.76 |
| ▸ | HPGD | P15428 | 1/20 | 0.76 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.76 |
| ▸ | NPC1 | O15118 | 3/20 | 0.76 |
| ▸ | RAB9A | P51151 | 3/20 | 0.76 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.76 |
| ▸ | CYP1A1 | P04798 | 1/20 | 0.71 |
| ▸ | CYP1B1 | Q16678 | 1/20 | 0.71 |
| ▸ | ABCG2 | Q9UNQ0 | 2/20 | 0.68 |
| ▸ | MEN1 | O00255 | 2/20 | 0.65 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.65 |
| ▸ | RELA | Q04206 | 2/20 | 0.65 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.64 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.63 |
| ▸ | MAOB | P27338 | 1/20 | 0.63 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.63 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7100049 | 1.00 | TNFRSF1A (0.84) | TNFRSF1AMAPTLMNACTSLCTSB | |
| SCHEMBL30383266 | 0.92 | TNFRSF1A (1.00) | TNFRSF1AMAPTLMNACTSLCTSB | |
| SCHEMBL30674925 | 0.92 | TNFRSF1A (1.00) | TNFRSF1AMAPTLMNACTSLCTSB | |
| SCHEMBL3215700 | 0.92 | TNFRSF1A (1.00) | TNFRSF1AMAPTLMNACTSLCTSB | |
| SCHEMBL3215707 | 0.92 | TNFRSF1A (1.00) | TNFRSF1AMAPTLMNACTSLCTSB | |
| SCHEMBL7099538 | 0.89 | ABCG2 (0.86) | TNFRSF1AMAPTLMNACTSLCTSB | |
| SCHEMBL20565018 | 0.89 | ABCG2 (0.86) | TNFRSF1AMAPTLMNACTSLCTSB | |
| SCHEMBL29394843 | 0.89 | ABCG2 (0.86) | TNFRSF1AMAPTLMNACTSLCTSB | |
| SCHEMBL7180313 | 0.88 | TNFRSF1A (0.86) | TNFRSF1AMAPTLMNACTSLCTSB | |
| SCHEMBL29600833 | 0.88 | TNFRSF1A (0.86) | TNFRSF1AMAPTLMNACTSLCTSB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12447137-B2 | Composition for prevention, amelioration, or treatment of cancer | EWHA University—Industry Collaboration Foundation (KR) | 2025-10-21 | — | — | US | disclosed |
| CN-114051408-B | Composition for preventing, ameliorating, or treating cancer | 梨花女子大学校产学协力团 | 2025-02-07 | — | — | CN | disclosed |
| US-20220226263-A1 | Composition for Prevention, Amelioration, or Treatment of Cancer | CHA UNIVERSITY INDUSTRY-ACADEMIC COOOPERATION FOUNDATION (KR) | 2022-07-21 | — | — | US | disclosed |
| EP-3977988-A1 | COMPOSITION FOR PREVENTION, AMELIORATION, OR TREATMENT OF CANCER | Ewha University-Industry Collaboration Foundation (KR) | 2022-04-06 | — | — | EP | disclosed |
| CN-114051408-A | Composition for preventing, ameliorating, or treating cancer | 梨花女子大学校产学协力团 | 2022-02-15 | — | — | CN | disclosed |
| WO-2020242201-A1 | COMPOSITION FOR PREVENTION, AMELIORATION, OR TREATMENT OF CANCER | 이화여자대학교 산학협력단 | 2020-12-03 | — | — | WO | disclosed |
| US-20200190024-A1 | NOVEL COMPOUND AND PHARMACEUTICAL COMPOSITION COMPRISING SAME AS ACTIVE INGREDIENT | CHA UNIVERSITY INDUSTRY-ACADEMIC COOPERATION FOUNDATION (KR) | 2020-06-18 | — | — | US | disclosed |
| CN-102397269-A | Application of chalcone compounds in preparations of inflammation resisting medicines | WENZHOU MEDICAL COLLEGE | 2012-04-04 | — | — | CN | disclosed |
| US-6603046-B1 | The invention is drawn to novel bis-aromatic a, beta -unsaturated ketones. The compounds are useful in the treatment and prophylaxis of diseases caused by parasites or bacteria. | LICA PHARMACEUTICALS A/S (DK) | 2003-08-05 | — | — | US | disclosed |
| EP-0634927-B1 | TREATMENT AND PROPHYLAXIS OF DISEASES CAUSED BY PARASITES, OR BACTERIA | LICA PHARMACEUTICALS AS (DK) | 2001-07-04 | — | — | EP | disclosed |
| US-5985935-A | PARASITICIDES OR BACTERICIDES | STATENS SERUMINSTITUT (DK) | 1999-11-16 | — | — | US | disclosed |
| EP-0634927-A1 | TREATMENT AND PROPHYLAXIS OF DISEASES CAUSED BY PARASITES, OR BACTERIA | STATENS SERUMINSTITUT (DK) | 1995-01-25 | — | — | EP | disclosed |
| WO-1993017671-A1 | TREATMENT AND PROPHYLAXIS OF DISEASES CAUSED BY PARASITES, OR BACTERIA | STATENS SERUMINSTITUT (DK) | 1993-09-16 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200190024-A1 | NOVEL COMPOUND AND PHARMACEUTICAL COMPOSITION COMPRISING SAME AS ACTIVE INGREDIENT | PRKAA1, PRKAA2, PRKAG1 | TNFRSF1A 3803/4885MAPT 46/4885LMNA 1969/4885 |
| US-20220226263-A1 | Composition for Prevention, Amelioration, or Treatment of Cancer | FABP2, FABP1, TSG101 | TNFRSF1A 3114/4885MAPT 3261/4885LMNA 1370/4885 |
| US-12447137-B2 | Composition for prevention, amelioration, or treatment of cancer | GSTO1, FABP1, GSTK1 | TNFRSF1A 3820/4885MAPT 4437/4885LMNA 837/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.